期刊文献+

ELAM-1在鼻咽癌组织中表达及其与临床特征关系的研究 被引量:6

EXPRESSION OF ELAM-1 IN NASOPHRYNGEAL CARCINOMA AND ITS CORRELATION WITH CLINICAL FEATURE
下载PDF
导出
摘要 目的:探讨内皮性白细胞黏附分子-1(ELAM-1)在鼻咽癌组织中的表达及其与临床特征的关系。方法:应用免疫组织化学染色技术检测46例鼻咽癌患者组织中ELAM-1的表达,按转移与否分为转移组和非转移组,比较两组ELAM-1表达的阳性率,并分析ELAM-1表达等级与T分期、临床TNM分期、年龄和性别之间的关系。结果:46例鼻咽癌患者中,29例发生转移,转移率为63%。转移组ELAM-1表达的阳性率为93.1%(27/29),非转移组ELAM-1表达的阳性率为23.5%(4/17),两组阳性率比较差异有统计学意义(χ2=23.607,P=0.000),并且转移与ELAM-1表达等级呈正相关关系(rs=0.571,P=0.000)。ELAM-1表达等级与T分期、临床TNM分期、年龄、性别无关(P>0.05)。结论:ELAM-1异常表达有助于鼻咽癌预后判断,但与临床特征中的预后因素无相关性。 Objective: To investigate the expression of EMLA-1 in nasopharyngeal carcinoma (NPC) and its correlation with clinical feature. Methods: Immunohistochemical SP method was used to detect the expression of EMLA-1 in 46 NPC tissues. And these samples were divided into metastasis group and non-metastasis group according metastatic condition. Then, compared the positive rate of ELAM-1 in the two groups and analyzed the relationship between the expression grade of ELAM-1 and clinical parameters including age, gender, clinical stage, T stage. Results: 29 cases of 46 case with NPC had occurred metastasis and the rate of metastasis accounted for 63%. Among the metastasis group, 93.1% (27/29) tissues expressed E- LAM-1, while the positive rate of ELAM-1 in non-metastasis was just 23.5% ,there was significant different between the positive rate of ELAM-1 in the two groups (χ^2=23. 607, P =0. 000). Furthermore, statistic analyze showed that there was a positive correlation between the grade of ELAM-1 expression and metastasis(rs=0. 571, P=0. 000),but there were not relationship with clinical staging, T staging, age and gender (P 〉 0.05). Conclusion: The abnormal expression of ELAM-1 can be helpful for prognosis of NPC, but it has no correlation with clinical parameters.
出处 《广西医科大学学报》 CAS 2015年第3期372-375,共4页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.81260334和81460452)
关键词 鼻咽癌 ELAM-1 转移 nasophryngeal carcinoma ELAM-1 metastases
  • 相关文献

参考文献10

二级参考文献100

共引文献390

同被引文献80

  • 1朱永钳,陈立光,侯庆仪.^(11)C-胆碱的体内生物分布和PET显像[J].循证医学,2006,6(6):382-384. 被引量:1
  • 2Sheng Y, Liao LD, Thakor NV, et al. Nanoparticles for molecular imaging[J].J Biomed Nanotechnol 2014, 10 (10) : 2641-2676.
  • 3Jubeli E, Moine L, Vergnaud- 6auduchon J, et al. E-selectin as a target For drug delivery and molecular imaging[J]. J Control Release 2012, 158(2):194-206.
  • 4Yasmin-Karim S, King MR, Messing EM, et al. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis[J].Oncotarget 2014, 5(23):12097-12110.
  • 5Leung K, Sialy Lewisx mimetic conjugated to pegylated ultrasmall superparamagnet ic iron oxide nanoparticles[J]. Molecular Imaging and Contrast Agent Database. 2009, (5)2004- 2013.
  • 6Mbeh DR, Javanbakht T, Tabet L, et al. Protein Corona Formation on Magnetite Nanoparticles: Effects of Culture Medium Composition, and Its Consequences on Superparamagnetic Nanoparticle Cytotoxicity[J]. J Biomed Nanotechnol 2015, 11(5): 828- 840.
  • 7Shahnaz G, Kremser C, Reinisch A, et al. Efficient MRI labeling of endothelial progenitor ceils: thiolated surface superparamagnetic design of stabilized iron nanoparticles[J]. Eur J Biopharm 2013, 85(3 Pt A) oxide Pharm : 346-355.
  • 8Cuny L, Herrling MP, Suthausen G, et al. Magnetic resonance imaging reveals detailed spatial and temporal distribution of iron-based nanoparticles transported through water-saturated porous media[J].J Contam Hydrol 2015, 182:51-62.
  • 9Laurent S,Vander Elst L, Fu Y,et al.Synthesis and physicochemical characterization of Gd-DTPA-B (sIx)A,a new MRI contrast agent targeted to inflammation [ J ].Bioconjug Chem, 2004, 15 ( 1 ) : 99-103.
  • 10Basilion JP,Yeon S,Botnar R.Magnetic resonance imaging: utility as a molecular imaging modality[ J ].Curr Top Dev Biol, 2005,70 : 1-33.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部